Report cover image

Strategic Intelligence: Genomics (2025)

Publisher GlobalData
Published Mar 14, 2025
Length 46 Pages
SKU # GBDT19975412

Description

Strategic Intelligence: Genomics (2025)

Summary

Genomics refers to the study of an entire set of DNA within an organism. This includes researching their molecular components, structures and functions of genes, and developing technologies that map and edit sequences of DNA. There are many facets to the genomics market, like direct-to-consumer genetic (DTC-GT), prenatal screening, carrier, cancer, human leukocyte antigen (HLA) typing, and rare disease testing.

DTC-GT had been a rapidly expanding market that generated substantial amounts of revenue and public interest. DTC-GT is one format a person can get genetic testing through, the other option is through a healthcare provider. Thus, test types like genetic risk and carrier screening can be seen in both test formats. However, some of these DTC-GT tests can tell you if you have genetic markers for certain cancers or diseases. It has gained public scrutiny over privacy concerns over the service providers' handling of consumers’ genomic data. For instance, in 2023, there was a huge security breach of seven million people by 23andMe. Although this market had grown remarkably in earlier years, a slower growth rate in the past couple of years suggests the market has approached saturation, with continued declining future usage.

Scope
  • Alcohol consumption is one of the first focal points for changed behavior when consumers seek to pursue healthier lifestyles.
  • Half of drinkers globally state they are often or always influenced in their product choice by how an alcoholic beverage impacts their health and wellbeing.
  • More than two thirds of alcohol consumers find products that have been fortified with added nutrients to be somewhat or very appealing.
Reasons to Buy
  • Understand and identify the better for you alcohol drinks innovation trend that consumers are interested in.
  • Identify the specific aspects of healthiness that will appeal to consumers in the sector.
  • Access valuable strategic take-outs in the form of specific opportunities to enhance future decision-making and inform new product development.

Table of Contents

46 Pages
  • Executive Summary
    • Figure 1: Who are the leading players in the genomics theme, and where do they sit in the value chain?
    • Next generation sequencing
    • Sanger sequencing
    • Polymerase chain reaction
    • SNP-BeadArray chip technology
    • Technology trends
    • Macroeconomic trends
    • Regulatory trends
    • Figure 6: Genetic testing has six market segments
    • Direct-to-consumer genetic testing
    • Cancer biomarker testing
    • Rare disease testing
    • Non-invasive prenatal testing
    • Human leukocyte antigen type testing
    • Third-party data re-analysis
    • Timeline
    • M&A trends
    • Venture financing trends
    • Patent trends
    • Hiring trends
    • Figure 11: The genomics value chain
    • Technology
    • Genetic tests
    • Third-party data re-analysis
    • Public companies
    • Private companies
    • Medical devices sector scorecard
    • GlobalData reports
    • Figure 19: Our five-step approach for generating a sector scorecard
  • About GlobalData
  • Contact Us

Search Inside Report

How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.